{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:02:49Z","timestamp":1775008969122,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":684,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Franklin & Marshall College Eyler Fund"},{"DOI":"10.13039\/100000870","name":"John D. and Catherine T. McArthur Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000870","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ymgme.2011.07.003","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T03:36:07Z","timestamp":1310787367000},"page":"93-106","source":"Crossref","is-referenced-by-count":84,"title":["Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: Focus on cerebral amino acid influx"],"prefix":"10.1016","volume":"104","author":[{"given":"Kevin A.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Brumbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Wardley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Tortorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann B.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik G.","family":"Puffenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Holmes","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2011.07.003_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajmg.1320410122","article-title":"Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania","volume":"41","author":"Morton","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0010","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/brain\/awm058","article-title":"Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency","volume":"130","author":"Strauss","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0015","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1203\/01.pdr.0000219387.79887.86","article-title":"Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency","volume":"59","author":"Kolker","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajmg.c.20007","article-title":"Type I glutaric aciduria, part 1: natural history of 77 patients","volume":"121","author":"Strauss","year":"2003","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1023\/B:BOLI.0000045777.82784.74","article-title":"Glutaric aciduria type I: outcome in the Republic of Ireland","volume":"27","author":"Naughten","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejpn.2003.12.007","article-title":"Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1","volume":"8","author":"Kyllerman","year":"2004","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10545-008-0912-z","article-title":"Glutaric aciduria type I: outcome following detection by newborn screening","volume":"31","author":"Bijarnia","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1023\/B:BOLI.0000045768.38073.22","article-title":"Challenges for basic research in glutaryl-CoA dehydrogenase deficiency","volume":"27","author":"Kolker","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0045","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.22095","article-title":"Use of guidelines improves the neurological outcome in glutaric aciduria type I","volume":"68","author":"Heringer","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2008.03.005","article-title":"Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome","volume":"94","author":"Boneh","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/brain\/awh401","article-title":"Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort","volume":"128","author":"Funk","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0060","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1007\/BF02138786","article-title":"Neurological manifestations of organic acid disorders","volume":"153","author":"Hoffmann","year":"1994","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0065","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/brain\/awl009","article-title":"A diet-induced mouse model for glutaric aciduria type I","volume":"129","author":"Zinnanti","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1471-4159.2006.03813.x","article-title":"Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood\u2013brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency","volume":"97","author":"Sauer","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10545-008-0825-x","article-title":"Membrane translocation of glutaric acid and its derivatives","volume":"31","author":"Muhlhausen","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0080","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1016\/S0021-9258(19)77829-6","article-title":"Conservation of central nervous system glutaryl-coenzyme A dehydrogenase in fruit-eating bats with glutaric aciduria and deficient hepatic glutaryl-coenzyme A dehydrogenase","volume":"263","author":"McMillan","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/brain\/awh482","article-title":"Glutaric aciduria type 1: a clinician's view of progress","volume":"128","author":"Strauss","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbadis.2010.03.003","article-title":"Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood\u2013brain barrier and the choroid plexus","volume":"1802","author":"Sauer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0095","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1471-4159.2002.00986.x","article-title":"Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate","volume":"82","author":"Hassel","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-4838(01)00147-9","article-title":"Molecular enzymology of carnitine transfer and transport","volume":"1546","author":"Ramsay","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mam.2004.06.001","article-title":"Carnitine: transport and physiological functions in the brain","volume":"25","author":"Nalecz","year":"2004","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-8981(77)90304-7","article-title":"Demonstration of N-dicarboxyl-mono-glycines in dicarboxylic acidurias by mass fragmentography","volume":"78","author":"Gregersen","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ajhg.2008.09.018","article-title":"Genetic mapping of glutaric aciduria, type 3, to chromosome 7 and identification of mutations in c7orf10","volume":"83","author":"Sherman","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0120","series-title":"Introduction to the Blood\u2013Brain Barrier","first-page":"188","article-title":"Blood\u2013brain barrier amino acid transport","author":"Smith","year":"1998"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0125","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1093\/brain\/awl137","article-title":"Lysine intake and neurotoxicity in glutaric aciduria type I: towards a rationale for therapy?","volume":"129","author":"Kolker","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0130","doi-asserted-by":"crossref","first-page":"E412","DOI":"10.1152\/ajpendo.00007.2006","article-title":"Cationic amino acid transport across the blood\u2013brain barrier is mediated exclusively by system y+","volume":"291","author":"O'Kane","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0135","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1471-4159.1993.tb13428.x","article-title":"Identification of the cationic amino acid transporter (System y+) of the rat blood\u2013brain barrier","volume":"60","author":"Stoll","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10545-006-0451-4","article-title":"Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency","volume":"30","author":"Kolker","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/ajcn\/30.4.499","article-title":"Breast milk composition in Ethiopian and Swedish mothers. III. Amino acids and other nitrogenous substances","volume":"30","author":"Svanberg","year":"1977","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/adc.80.5.404","article-title":"Glutaric aciduria and suspected child abuse","volume":"80","author":"Morris","year":"1999","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2007-973806","article-title":"Neurosurgical treatment for hydrocephalus, subdural hematomas, and arachnoid cysts in glutaric aciduria type 1","volume":"27","author":"Martinez-Lage","year":"1996","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/brain\/awp297","article-title":"Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency","volume":"133","author":"Strauss","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","article-title":"Classical maple syrup urine disease and brain development: principles of management and formula design","volume":"99","author":"Strauss","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymgme.2007.02.012","article-title":"Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency","volume":"91","author":"Strauss","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0175","series-title":"Underimmunization in Ohio's Amish: Parental Fears Are a Greater Obstacle Than Access to Care Pediatrics","author":"Wenger","year":"2011"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W","article-title":"Brain metabolism of branched-chain amino acids","volume":"21","author":"Yudkoff","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11064-008-9840-4","article-title":"Glial metabolism of isoleucine","volume":"34","author":"Murin","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.freeradbiomed.2010.05.023","article-title":"Histidine, cystine, glutamine, and threonine collectively protect astrocytes from the toxicity of zinc","volume":"49","author":"Ralph","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jbmr.5650050702","article-title":"Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover","volume":"5","author":"Beardsworth","year":"1990","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0200","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/clinchem\/44.7.1540","article-title":"Water, fat, nitrogen, and sugar content in feces: reference intervals in children","volume":"44","author":"Rivero-Marcotegui","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0205","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0009-8981(61)90120-6","article-title":"Ion-exchange chromatography of urinary amino acids. I. Normal children","volume":"6","author":"Carver","year":"1961","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0210","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1542\/peds.36.4.592","article-title":"Endogenous renal clearance rates of free amino acids in pre-pubertal children","volume":"36","author":"Scriver","year":"1965","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1172\/JCI105155","article-title":"Body composition in severe infantile malnutrition","volume":"44","author":"Garrow","year":"1965","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0220","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1023\/B:BOLI.0000045775.03183.48","article-title":"Reduction of lysine intake while avoiding malnutrition\u2014major goals and major problems in dietary treatment of glutaryl-CoA dehydrogenase deficiency","volume":"27","author":"Muller","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/11.4.347","article-title":"Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I","volume":"11","author":"Koeller","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0230","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s11064-005-7711-9","article-title":"Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats","volume":"30","author":"Ferreira Gda","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0235","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/WNL.55.9.1249","article-title":"Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum","volume":"55","author":"Calabresi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/brain\/awq269","article-title":"Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I","volume":"134","author":"Sauer","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0245","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1172\/JCI31617","article-title":"Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I","volume":"117","author":"Zinnanti","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0250","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/jn\/128.12.2427","article-title":"Mitochondrial lysine uptake limits hepatic lysine oxidation in rats fed diets containing 5, 20 or 60% casein","volume":"128","author":"Blemings","year":"1998","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0255","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jn\/124.8.1215","article-title":"Lysine-alpha-ketoglutarate reductase and saccharopine dehydrogenase are located only in the mitochondrial matrix in rat liver","volume":"124","author":"Blemings","year":"1994","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0260","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yrtph.2008.01.004","article-title":"Risk assessment for the amino acids taurine, L-glutamine and L-arginine","volume":"50","author":"Shao","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S000711450769936X","article-title":"Amino acids and immune function","volume":"98","author":"Li","year":"2007","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0270","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/CCM.0b013e3181ffd9f7","article-title":"Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis","volume":"39","author":"Davis","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/CS20080444","article-title":"Arginine, citrulline and nitric oxide metabolism in sepsis","volume":"117","author":"Kao","year":"2009","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0280","doi-asserted-by":"crossref","first-page":"2826S","DOI":"10.1093\/jn\/134.10.2826S","article-title":"Arginine transport in catabolic disease states","volume":"134","author":"Pan","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0285","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa066596","article-title":"Survival after treatment with phenylacetate and benzoate for urea-cycle disorders","volume":"356","author":"Enns","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0290","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/alcalc\/agl032","article-title":"Arginine challenge unravels persistent disturbances of urea cycle and gluconeogenesis in abstinent alcoholics","volume":"41","author":"Hasselblatt","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0295","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1097\/01.CCM.0000242757.26245.03","article-title":"Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock","volume":"34","author":"Kalil","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0300","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1177\/01486071050290S1S70","article-title":"The role of arginine in infection and sepsis","volume":"29","author":"Luiking","year":"2005","journal-title":"JPEN J. Parenter. Enteral. Nutr."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.c.20008","article-title":"Type I glutaric aciduria, part 2: a model of acute striatal necrosis","volume":"121","author":"Strauss","year":"2003","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0310","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1023\/A:1005390105171","article-title":"Diagnosis and management of glutaric aciduria type I","volume":"21","author":"Baric","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0315","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF00965124","article-title":"Lysine metabolism in the human and the monkey: demonstration of pipecolic acid formation in the brain and other organs","volume":"7","author":"Chang","year":"1982","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/oxfordjournals.jbchem.a124086","article-title":"Studies on the substrate specificity of the inducible and non-inducible acyl-CoA oxidases from rat kidney peroxisomes","volume":"113","author":"Wanders","year":"1993","journal-title":"J. Biochem."},{"key":"10.1016\/j.ymgme.2011.07.003_bb0325","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awp112","article-title":"Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I","volume":"132","author":"Harting","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0330","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1212\/01.WNL.0000167428.12417.B2","article-title":"Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency","volume":"64","author":"Kulkens","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0335","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1212\/WNL.60.8.1399","article-title":"Adult onset glutaric aciduria type I presenting with a leukoencephalopathy","volume":"60","author":"Kolker","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2011.07.003_bb0340","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/01.WNL.0000036616.11962.3C","article-title":"Adult onset glutaric aciduria type I presenting with a leukoencephalopathy","volume":"59","author":"Bahr","year":"2002","journal-title":"Neurology"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211002162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211002162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:36:24Z","timestamp":1686198984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719211002162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":68,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1096719211002162"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2011.07.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}